Sponsor Pipeline

Andrew P. Groves Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06896110 Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma Glioblastoma (GBM) Enrolling by Invitation
Disease Areas
Glioblastoma (1) Glioma (1) Sarcoma (1)
Get alerts when Andrew P. Groves's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free